Clinical trial
Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South…
NCT00138047 · Johns Hopkins Bloomberg School of Public Health, Other · Completed
Key facts
| NCT number | NCT00138047 |
|---|---|
| Title | Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa |
| Official title | Randomized, Double-Blind, Placebo-Controlled Trial of Zinc Supplementation in HIV-1-Infected Children |
| Lead sponsor | Johns Hopkins Bloomberg School of Public Health, Other |
| Collaborators | United States Agency for International Development (USAID) U.S. Fed University of KwaZulu Grey's Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | zinc supplementation |
| Enrollment | 100 |
| Start date | Mar 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Aug 30, 2005 |
| Last update posted | Dec 5, 2005 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: